Breaking News
Get 45% Off 0
Investors lost 37% by missing this ONE signal 😵
Read now

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Chemicals Industry Stock Outlook - November 2017 By Zacks Investment Research - Nov 08, 2017

The chemical industry is back on the growth path after being roiled by the global economic crisis. The highly cyclical industry has enjoyed a positive run this year, helped by an upswing in the world...

Zacks Investment Research
Favorable Trend In Q4 Earnings Estimates By Zacks Investment Research - Nov 08, 2017

Note: The following is an excerpt from this week’sEarnings Trends report. You can access the full report that contains detailed historical actual and estimates for the current and following...

Zacks Investment Research
Can Disney Escape Hollywood Woes In Q4? By Zacks Investment Research - Nov 08, 2017

Most big-name brands have already reported earnings this quarter, and therefore, a slew of investors now look longingly to the fourth quarter and the full fiscal year. Nevertheless, industry shakers...

Zacks Investment Research
Here's Why You Should Add BP To Your Portfolio Right Away By Zacks Investment Research - Nov 08, 2017

On Nov 7, BP (LON:BP) Plc (NYSE:BP) was upgraded to a Zacks Rank #2 (Buy).Why the Upgrade? Along with third-quarter 2017 results, BP announced expectations of a sequential improvement in production...

Zacks Investment Research
AmTrust To Transfer Majority Of U.S.-Based Fee Businesses By Zacks Investment Research - Nov 08, 2017

AmTrust Financial Services, Inc. (NASDAQ:AFSI) inked a deal with Madison Dearborn Partners (“MDP”) to transfer 51% equity stake of its U.S.-based fee businesses to the latter. The...

Zacks Investment Research
Why Disney's Parks Could Lift Its Q4 Earnings By Zacks Investment Research - Nov 08, 2017

Almost as fast as it came, the third-quarter earnings season nears its end. But while some investors begin to look down the road, others wait with great anticipation for a few remaining S&P 500...

Zacks Investment Research
MMM, HON, LUK: Which Conglomerate To Bet On Post-Q3 Earnings? By Zacks Investment Research - Nov 08, 2017

As the third-quarter earnings season heads to its last lap, various analysis and comparisons are being done by industry peers to gauge the underlying metrics and relative performance. Let us perform a...

Dr. Duru
Republican Tax Plan Does Not Worry KB Home By Dr. Duru - Nov 08, 2017

The angst may already be fading away.Last week, I chronicled the carnage across the stocks of home builders that erupted in response to the Republican plan for tax reform that includes a reduction in...

Zacks Investment Research
What To Expect From Nvidia's Q3 Earnings Report By Zacks Investment Research - Nov 08, 2017

Q3 earnings season is finally starting to wind down, and in nearly every sector of the market, investors have been able to find exciting results. Nevertheless, a few marquee reports remain to be...

Zacks Investment Research
Will ESPN Hurt Disney's Q4 Earnings? By Zacks Investment Research - Nov 08, 2017

As we near the end of the third-quarter earnings season, many investors are ready to look ahead to the fourth quarter and start working out how companies might perform for the full year. Yet there are...

Zacks Investment Research
Buy These 4 Stocks To Profit From Bitcoin's Soaring Popularity By Zacks Investment Research - Nov 08, 2017

Bitcoin is one of the most popular cyrptocurrencies on the market, primarily backed by a rising user base. According to coinmarketcap.com, the market capitalization of the currency presently stands at...

Zacks Investment Research
Jazz Pharmaceuticals (JAZZ) Q3 Earnings Top, 2017 View Cut By Zacks Investment Research - Nov 08, 2017

Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) reported third-quarter 2017 adjusted earnings of $3.22 per share, beating the Zacks Consensus Estimate of $2.89. The bottom line also...

Zacks Investment Research
Mallinckrodt (MNK) Earnings, Sales Decline Y/Y In Q3 By Zacks Investment Research - Nov 08, 2017

Mallinckrodt Public Limited Company (NYSE:MNK) reported disappointing results for third-quarter 2017.The company reported adjusted earnings of $1.97 per share in the reported quarter, down from the...

Continue with Apple
Continue with Google
or
Sign up with Email